Treatment of multiple myeloma with an allogeneic peripheral blood stem cell transplantation using a non-myeloablative conditioning regimen

被引：0
|
作者：
Kmonicek, M
Zak, P
Jebavy, L
Maisnar, V
Maly, J
机构：
来源：
BONE MARROW TRANSPLANTATION | 2003年 / 31卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S86 / S86
页数：1
相关论文
共 50 条
  • [31] Allogeneic hematopoietic stem cell transplantation for Pesaro IIIβ-thalassemia major using fludarabine-based myeloablative or non-myeloablative conditioning regimen.
    Zhu, KG
    Gu, J
    Zhang, T
    Zhong, J
    BLOOD, 2005, 106 (11) : 35B - 35B
  • [32] Allogeneic stem cell transplantation using non-myeloablative transplant regimens
    Körbling, M
    Khouri, I
    HIGH-DOSE THERAPY AND TRANSPLANTATION OF HAEMATOPOIETIC STEM CELLS, 2000, : 175 - 184
  • [33] Allogenic peripheral blood stem cell infusion may induce chimerism after non-myeloablative conditioning regimen
    De Stefano, F
    Casarino, L
    Corsetti, MT
    Verdiani, S
    Peirano, L
    Carella, AM
    Celesti, R
    EXPERIMENTAL HEMATOLOGY, 1999, 27 (07) : 132 - 132
  • [34] GVHD and CMV antigenemia after allogeneic peripheral blood stem cell transplantation: Comparison between myeloablative and non-myeloablative (MINI) conditioning regimens.
    Reddy, V
    Pollock, BH
    Sharda, S
    Hopkins, J
    Weeks, F
    Manion, K
    Roque, D
    Leather, HL
    Finiewicz, KJ
    Khan, SA
    Mehta, P
    Moreb, JS
    Wingard, JR
    BLOOD, 2000, 96 (11) : 191A - 191A
  • [35] New non-myeloablative conditioning regimen for multiple sclerosis patients undergoing autologous hematopoietic stem cell transplantation
    Novik, Andrei A.
    Kuznetsov, Alexey N.
    Melnichenko, Vladimir Y.
    Fedorenko, Denis A.
    Ionova, Tatiana L.
    Kruglina, Ruslana V.
    Kartashov, Andrei V.
    Gorodokin, Gary J.
    MULTIPLE SCLEROSIS, 2008, 14 : S169 - S169
  • [36] Safe and effective use of outpatient non-myeloablative allogeneic stem cell transplantation for myeloma
    P Campbell
    P Walker
    S Avery
    S Patil
    D Curtis
    A Schwarer
    A Wei
    A Kalff
    J Muirhead
    A Spencer
    Blood Cancer Journal, 2014, 4 : e213 - e213
  • [37] Analysis of immune reconstitution in adults undergoing non-myeloablative allogeneic peripheral blood stem cell transplantation
    Guo, HF
    Qiao, ZH
    Su, LP
    Zhu, L
    Wang, HW
    Ma, LM
    HAEMATOLOGICA, 2003, 88 (07) : 833 - 835
  • [38] Red blood cell and reticulocyte chimerism studies in non-myeloablative allogeneic peripheral blood haematopoietic stem cell transplantation
    Harritshoj, L
    Berkowicz, A
    Petersen, SL
    Madsen, HO
    Ryder, LP
    Vindelov, L
    Andersen, P
    Dickmeiss, E
    BONE MARROW TRANSPLANTATION, 2004, 33 : S116 - S117
  • [39] Safe and effective use of outpatient non-myeloablative allogeneic stem cell transplantation for myeloma
    Campbell, P.
    Walker, P.
    Avery, S.
    Patil, S.
    Curtis, D.
    Schwarer, A.
    Wei, A.
    Kalff, A.
    Muirhead, J.
    Spencer, A.
    BLOOD CANCER JOURNAL, 2014, 4 : e213 - e213
  • [40] Non-myeloablative peripheral blood stem cell (PBSC) allografts following cytoreductive autotransplants for treatment of multiple myeloma (MM).
    Molina, A
    McSweeney, P
    Maloney, DG
    Sandmaier, B
    Bensinger, W
    Nash, R
    Chauncey, T
    Appelbaum, FR
    Storb, R
    BLOOD, 1999, 94 (10) : 347A - 347A
12345